Profound Medical Corp Asset Resilience Ratio
Profound Medical Corp asset resilience ratio. Profound Medical Corp (PRN) has an Asset Resilience Ratio of 67.66% as of June 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Profound Medical Corp (PRN) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Profound Medical Corp (2015–2016)
Asset resilience ratio of Profound Medical Corp from 2015 to 2016. This chart shows how Profound Medical Corp's Asset Resilience Ratio has changed over time. Read Profound Medical Corp (PRN) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Profound Medical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Profound Medical Corp (PRN) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$7.73 Million | 67.66% |
| Total Liquid Assets | CA$7.73 Million | 67.66% |
Asset Resilience Insights
- Very High Liquidity: Profound Medical Corp maintains exceptional liquid asset reserves at 67.66% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Profound Medical Corp Industry Peers by Asset Resilience Ratio
Compare Profound Medical Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Profound Medical Corp Asset Resilience Ratio by Year (2015–2016)
Profound Medical Corp asset resilience ratio by year from 2015 to 2016. The table below shows the annual Asset Resilience Ratio data for Profound Medical Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2016-12-31 | 0.00% | CA$0.00 ≈ $0.00 |
CA$17.63 Million ≈ $12.75 Million |
-- |
| 2015-12-31 | 47.19% | CA$7.21 Million ≈ $5.21 Million |
CA$15.27 Million ≈ $11.05 Million |
-- |
About Profound Medical Corp
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedb… Read more